These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24655954)

  • 1. Serum Endocan correlated with stage of chronic kidney disease and deterioration in renal transplant recipients.
    Su YH; Shu KH; Hu CP; Cheng CH; Wu MJ; Yu TM; Chuang YW; Huang ST; Chen CH
    Transplant Proc; 2014; 46(2):323-7. PubMed ID: 24655954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocan Concentration in Kidney Transplant Recipients.
    Malyszko J; Koc-Żórawska E; Malyszko JS
    Transplant Proc; 2018; 50(6):1798-1801. PubMed ID: 30056903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
    Pawlak K; Mysliwiec M; Pawlak D
    Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocan Concentration and Chronic Inflammatory Process Among Heart Transplant Recipients.
    Przybylowski P; Wasilewski G; Koc-Żórawska E; Malyszko J
    Transplant Proc; 2016 Jun; 48(5):1781-5. PubMed ID: 27496491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.
    Yilmaz MI; Siriopol D; Saglam M; Kurt YG; Unal HU; Eyileten T; Gok M; Cetinkaya H; Oguz Y; Sari S; Vural A; Mititiuc I; Covic A; Kanbay M
    Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocan as a marker of microvascular inflammation in kidney transplant recipients.
    Lee YH; Kim SY; Moon H; Seo JW; Kim DJ; Park SH; Kim YG; Moon JY; Kim JS; Jeong KH; Lim SJ; Kim CD; Park JB; Chung BH; Kim YH; Yang J; Yang HI; Kim KS; Lee SH
    Sci Rep; 2019 Feb; 9(1):1854. PubMed ID: 30755622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship between Vascular Biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and Renal Function in Chronic Kidney Disease, IgA Nephropathy: A Cross-Sectional Study.
    Sági B; Vas T; Gál C; Horváth-Szalai Z; Kőszegi T; Nagy J; Csiky B; Kovács TJ
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocan: A novel inflammatory indicator in cardiovascular disease?
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A
    Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
    Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased circulating endocan in patients with cirrhosis: relation to bacterial infection and severity of disease.
    Zuwala-Jagiello J; Simon K; Kukla M; Murawska-Cialowicz E; Gorka-Dynysiewicz J; Grzebyk E; Pazgan-Simon M
    J Physiol Pharmacol; 2017 Apr; 68(2):273-282. PubMed ID: 28614777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
    Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
    J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could "calprotectin" and "endocan" serve as "Troponin of Nephrologists"?
    Azimi A
    Med Hypotheses; 2017 Feb; 99():29-34. PubMed ID: 28110693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
    Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A
    Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study.
    Seifert ME; Ashoor IF; Chiang ML; Chishti AS; Dietzen DJ; Gipson DS; Janjua HS; Selewski DT; Hruska KA
    Pediatr Transplant; 2016 May; 20(3):378-87. PubMed ID: 26880121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
    Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients.
    Oka S; Obata Y; Sato S; Torigoe K; Sawa M; Abe S; Muta K; Ota Y; Kitamura M; Kawasaki S; Hirose M; Uramatsu T; Mukae H; Nishino T
    Med Sci Monit; 2017 Mar; 23():1464-1470. PubMed ID: 28343234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study.
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Kurtoglu E; Demir M; Celik T; Turker T; Iyisoy A
    Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic kidney disease in orthotopic heart transplant recipients and kidney allograft recipients using the new Chronic Kidney Disease Epidemiology Collaboration formula.
    Malyszko J; Przybylowski P; Malyszko JS; Iaina-Levin N; Sadowski J; Mysliwiec M
    Transplant Proc; 2010 Dec; 42(10):4251-4. PubMed ID: 21168676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.